We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Due to its unique high catalytic efficiency, high specific selectivity, mild reaction conditions and less waste discharge, bio-enzymes have expanded their practical effects in the pharmaceutical industry, especially in process substitution and greener pharmaceutical processes. It played an important role and its important status was widely recognized. The company has researched and developed a variety of special enzymes for the preparation of chiral intermediates, including carbonyl reductase, alcohol dehydrogenase, transaminase, lipase, acylase, nitrilase and so on. Based on the industrial data feedback from major customers, the total reaction yield increased by more than 10% on average, and the product yield per unit time increased by 40%-50% on average, compared with the original chemical conversion or resolution process. Emissions are reduced by more than 20%.
Enzymatic catalysis has been widely used in the production of heavy drugs such as atorvastatin, rosuvastatin, duloxetine and sitagliptin.